top of page

Download

Paper Metrics

0

Reads

0

Downloads

Citations:

2

Source: OpenAlex.org

openAlex-logo.png

Article Timeline

Published online:

10 Jan 2024

Accepted:

3 Jan 2024

Received:

23 Dec 2023

Open Access

Review

Molecular basis of dementia

Oliwia Szymanowicz, Sandra Pawlak, Ewelina Potocka, U. Goutor, Wojciech Kozubski and Jolanta Dorszewska

Author Affiliations

  • Oliwia Szymanowicz: Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

  • Sandra Pawlak: Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

  • Ewelina Potocka: Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

  • U. Goutor: Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

  • Wojciech Kozubski: Chair and Department of Neurology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

  • Jolanta Dorszewska: Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

Abstract

Dementia is a set of symptoms characterized by deterioration of memory and cognitive functions. Dementia diseases include Alzheimer's disease, Lewy body dementia, frontotemporal dementia, vascular dementia, and mixed dementia. This disease represents an escalating social issue, particularly in a society with an increasing elderly population. In 2019, 271,998 people succumbed to dementia, making Alzheimer's disease the sixth most prevalent cause of death. The pathophysiology of Alzheimer's disease is complex and not fully understood. It is a multifaceted disease, with its pathogenesis influenced by a combination of genetic, environmental, and lifestyle factors. One of the genes involved in the pathogenesis of the disease is the apolipoprotein E (APOE) gene, which is one of the most common risk factors for Alzheimer's disease. The significance of other genes, including presenilin genes (PSEN1 and PSEN2), the TREM2 gene, the MAPT gene, and the APP gene, linked to various forms of dementia, is also emphasized. Another issue is the growing number of identified genetic variants within genes implicated in the onset of dementia. Dementia diseases are also characterized by chemical alterations in the brain, including the accumulation of abnormal excitotoxic proteins, varying degrees of inflammation, and metabolic disorders. This article aims to summarize current discoveries in the field of dementia and highlight the significance of molecular factors in its pathogenesis. Gaining insight into the pathogenic mechanisms of dementia may allow for faster diagnosis of the disease and facilitate the creation of more efficient patient care plans.

Keywords

Dementia; neurocognitive disorder; mental disorder; mental decay and deterioration.

How to cite this article

Oliwia Szymanowicz, Sandra Pawlak, Ewelina Potocka, Wojciech Kozubski and Jolanta Dorszewska  (2023). Molecular basis of dementia. Journal of Multiscale Neuroscience 3(1), 53-63.

Conflict of Interest

The authors declare no conflict of interest.

Copyright

© 2024 The Author(s). Published by Neural Press. This is an open access article distributed under the terms and conditions of the CC BY 4.0 license.

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, Neural Press or the editors, and the reviewers. Any product that may be evaluated in this article, or claim that made by its manufacturer, is not guaranteed or endorsed by the publisher.

---

This article belongs to the Special IssueThis article belongs to the Special Issue

 Dementia in Neurological Disorders

Lead Editor:

Prof. Jolanta Dorszewska, DSc, PhD
Laboratory of Neurobiology, Department of Neurology
Poznan University of Medical Sciences, Poland
email: dorszewskaj@yahoo.com

bottom of page